Prevalence of mismatch repair mutations in colorectal carcinoma patients in Mangalore

---

Original Article

Author Details : Vineeth G Nair*, M H Shariff

Volume : 9, Issue : 2, Year : 2022

Article Page : 116-122

https://doi.org/10.18231/j.ijpo.2022.029

Suggest article by email

Get Permission

---

Abstract

Introduction: Colorectal cancer (CRC) is highly prevalent throughout the world and represents the 3rd most common cancer in men and the 2nd in women worldwide. Microsatellite instability (MSI) is a term used to denote a hypermutable phenotype caused by the loss of DNA mismatch repair (MMR) activity, and is a phenomenon now linked to the pathways of colorectal carcinogenesis. Compounding its importance is its integral association with Lynch syndrome, the most common cause for CRCs in young individuals. In the present study, we aimed to analyse the proportion of patients with risk of microsatellite instability by checking for loss of immunostaining for mismatch repair (MMR) proteins.
Materials and Methods: From January 2016 to December 2016 and May 2017 to October 2017, 40 consecutive newly diagnosed cases of colorectal cancer were included in the study. The expression of MMR proteins in the tumour tissue using IHC for MSH2, MSH6, MLH1 and PMS2 was studied.
Result: Among the 40 cases, 3 (7.5%) demonstrated loss of MMR proteins and 37 (92.5%) cases had intact nuclear expression. Out of the three cases with MMR loss, one showed concurrent loss of MLH1 and PMS2, the second showed concurrent loss of MSH2 and MSH6 and the third showed an isolated loss of MSH6.
Conclusion: Colorectal carcinomas showing MMR mutations are seen in the Mangalorean population. However, the incidence in our study was relatively low compared to most other studies, probably due to a variation in ethnicity.
 

Keywords: Microsatellite instability, Colorectal cancer, Mismatch repair, Lynch syndrome, IHC.

How to cite : Nair V G, Shariff M H, Prevalence of mismatch repair mutations in colorectal carcinoma patients in Mangalore. Indian J Pathol Oncol 2022;9(2):116-122

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.